Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

More atypical club hairs may indicate Telogen Effluvium.

The comment questions the study's methods for diagnosing hair loss, the type of injections used, the reliability of hair count as a measure, the lack of detail about the procedure, and disagrees with the conclusion about the effect of needling.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Pigtail hair is a sign of new hair growth and should be recognized in hair loss conditions like acute telogen effluvium.

Hair loss in a child was an early sign of Crohn's disease.

Public interest in hair loss increased during the COVID-19 pandemic.

Iron deficiency anemia is significantly linked to hair loss in childbearing women, and taking iron improves the condition.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Telogen effluvium is a condition that causes temporary hair loss.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.

Niosomal minoxidil, when applied topically, increases hair count more than conventional minoxidil solution.

AA-PRP injections effectively increase hair count and thickness for male pattern hair loss.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Estrogen can temporarily slow down hair growth but this can be reversed.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.